Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.J Am Acad Dermatol. 2007; 56: 968-973
- Dermatofibrosarcoma protuberans: a review of the literature.Dermatol Surg. 2012; 38: 537-551
- Incidence and Clinical Features of Rare Cutaneous Malignancies in Olmsted County, Minnesota, 2000 to 2010.Dermatol Surg. 2017; 43: 116-124
- Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.Cancer. 2000; 88: 2711-2720
- Outcomes of surgery for dermatofibrosarcoma protuberans.Eur J Surg Oncol. 2004; 30: 341-345
- Dermatofibrosarcoma protuberans.J Am Acad Dermatol. 1996; 35: 355-374
- Ring 22 chromosomes in dermatofibrosarcoma protuberans are low-level amplifiers of chromosome 17 and 22 sequences.Cancer Res. 1995; 55: 2400-2403
- Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment.J Clin Med. 2020; 9: 1752
- Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.Br J Dermatol. 2007; 157: 319-324
- A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.J Am Acad Dermatol. 2014; 71: 781-786
- Fibrosarcomatous change in dermatofibrosarcoma protuberans.Am J Surg Pathol. 1988; 12: 287-293
- Dermatofibrosarcoma protuberans.J Natl Compr Canc Netw. 2012; 10: 312-318
- Dermatofibrosarcoma protuberans.(Available at:) (Accessed January 18, 2022)
- Childhood dermatofibrosarcoma protuberans: role of preoperative imaging.J Am Acad Dermatol. 2005; 53: 76-83
- The efficacy of adjuvant radiotherapy in dermatofibrosarcoma protuberans: a systemic review and meta-analysis.J Eur Acad Dermatol Venereol. 2016; 30: 1107-1114
- Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.JAMA Dermatol. 2019; 155: 361-369
- Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review.Arch Dermatol. 2012; 148: 1055-1063
- Cutaneous mesenchymal tumors treated with Mohs micrographic surgery: a comprehensive review.Int J Dermatol. 2021; 60: 1334-1342
- Dermatofibrosarcoma protuberans: treatment and prognosis.Eur J Surg Oncol. 1992; 18: 241-248
- Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.Dermatol Clin. 2019; 37: 253-259
- Atypical Fibroxanthoma: The Washington University Experience.Dermatol Surg. 2019; 45: 1450-1458
- Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.Am J Surg Pathol. 2008; 32: 1111-1122
- CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker.J Cutan Pathol. 2006; 33: 24-28
- Surgical excision margins for fibrohistiocytic tumors, including atypical fibroxanthoma and undifferentiated pleomorphic sarcoma: A probability model based on a systematic review.J Am Acad Dermatol. 2021; (S0190-9622(21)02519-02526)
- Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.J Am Acad Dermatol. 2018; 79: 929-934.e6
- Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.Am J Surg Pathol. 2012; 36: 1317-1326
- Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated.J Cutan Pathol. 2016; 43: 101-112
- Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.J Am Acad Dermatol. 2018; 79: 853-859
- Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy.Anticancer Res. 2015; 35: 5717-5735
- Cutaneous Leiomyosarcoma: A SEER Database Analysis.Dermatol Surg. 2020; 46: 159-164
- Prognostic factors, treatment, and survival in cutaneous pleomorphic sarcoma.J Am Acad Dermatol. 2020; 83: 388-396
- Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study.J Am Acad Dermatol. 2020; 83: 809-816
- Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.Head Neck. 2011; 33: 661-667
- Spindle cell neoplasms encountered in dermatologic surgery: a review.Dermatol Surg. 2012; 38: 825-850
- Combined VEGFR and MAPK pathway inhibition in angiosarcoma.Sci Rep. 2021; 11: 9362
- Angiosarcoma of skin and soft tissue: a study of forty-four cases.Cancer. 1981; 48: 1907-1921
- Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.Cancer. 2003; 98: 1716-1726
- Myofibrosarcoma: a clinicopathologic study.Am J Surg Pathol. 2001; 25: 219-228
- Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors.Am J Surg Pathol. 1998; 22: 1228-1238
- Myofibrosarcoma.Virchows Arch. 2004; 445: 215-223
- Low-grade myofibrosarcoma of the head and neck: importance of surgical therapy.J Pediatr Hematol Oncol. 2004; 26: 119-120
- Myofibrosarcoma of the bone: a clinicopathologic study.Am J Surg Pathol. 2001; 25: 1501-1507
- Cutaneous leiomyosarcoma: dermal and subcutaneous.Australas J Dermatol. 2020; 61: 243-249
- Clinical and Histopathologic Findings of Cutaneous Leiomyosarcoma: Correlation with Prognosis in 12 Patients.Actas dermo-sifiliograficas. 2018; 109: 140-147
- Cutaneous leiomyosarcoma - Case report.J Med Life. 2014; 7: 270-273
- Primary Cutaneous Leiomyosarcoma of the Lower Extremity: A Case Report and Literature Review.Cureus. 2021; 13: e14282
- Cutaneous leiomyosarcoma: a 20-year retrospective study and review of the literature.An Bras Dermatol. 2021; 96: 278-283
- Leiomyosarcoma arising from scrofuloderma scar.Clin Exp Dermatol. 2008; 33: 776-778
- Cutaneous leiomyosarcoma.Am J Surg Pathol. 1997; 21: 979-987
- A Systematic Review of the Treatment of Superficial Leiomyosarcoma With Mohs Micrographic Surgery.Dermatol Surg. 2019; 45: 1437-1441
- Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes.J Am Acad Dermatol. 2014; 71: 919-925
- Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases.J Cutan Pathol. 1996; 23: 458-463
Article info
Publication history
Published online: October 27, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
